Pharmacological treatment of hepatorenal syndrome: a note of optimism.
Salerno
Francesco
F
Cazzaniga
Massimo
M
Gobbo
Giulia
G
D000418:Albumins / Q000494:pharmacology / Q000627:therapeutic use; D017704:Baroreflex / Q000187:drug effects / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002496:Central Venous Pressure / Q000187:drug effects / Q000502:physiology; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006530:Hepatorenal Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000503:physiopathology; D020896:Hypovolemia / Q000150:complications / Q000503:physiopathology; D007668:Kidney / Q000098:blood supply / Q000187:drug effects* / Q000503:physiopathology; D008236:Lypressin / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D009638:Norepinephrine / Q000494:pharmacology / Q000627:therapeutic use; D011167:Portacaval Shunt, Surgical / Q000706:statistics & numerical data; D012039:Regional Blood Flow / Q000187:drug effects* / Q000502:physiology; D012077:Renal Artery / Q000187:drug effects* / Q000503:physiopathology; D000077585:Terlipressin; D016896:Treatment Outcome; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology; D014662:Vasoconstrictor Agents / Q000494:pharmacology* / Q000627:therapeutic use
D000418:Albumins; D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin; D009638:Norepinephrine